Erlotinib in non-small cell lung cancer treatment: current status and future development
C Gridelli, MA Bareschino, C Schettino, A Rossi… - The …, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe the
molecular mechanism of action of erlotinib. Define clinical and molecular predictors of …
molecular mechanism of action of erlotinib. Define clinical and molecular predictors of …
Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development
C Gridelli, MA Bareschino, C Schettino, A Rossi… - The Oncologist, 2007 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Learning Objectives</jats: title>< jats: p> After completing this
course, the reader will be able to: Describe the molecular mechanism of action of erlotinib …
course, the reader will be able to: Describe the molecular mechanism of action of erlotinib …
Erlotinib in non-small cell lung cancer treatment: current status and future development.
C Gridelli, MA Bareschino, C Schettino, A Rossi… - The …, 2007 - europepmc.org
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
[PDF][PDF] Erlotinib in Non‐Small Cell Lung Cancer Treatment: Current Status and Future Development
C Gridelli, MA Bareschino, C Schettino, A Rossi… - The …, 2007 - Wiley Online Library
Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related mortality
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
[PDF][PDF] Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development
C GRIDELLI, MA BARESCHINO, C SCHETTINO… - Citeseer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
Erlotinib in non-small cell lung cancer treatment: current status and future development
C Gridelli, MA Bareschino, C Schettino… - The …, 2007 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
worldwide. Standard treatment approaches such as chemotherapy, radiotherapy, and …
[引用][C] Erlotinib in non-small cell lung cancer treatment: current status and future development
C Gridelli, M Bareschino, C Schettino, A Rossi… - THE …, 2007 - iris.unicampania.it
Erlotinib in non-small cell lung cancer treatment: current status and future development IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English …
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English …